Headache in patients with non-functioning pituitary adenoma before and after transsphenoidal surgery - a prospective study.
Pituitary
; 2024 May 20.
Article
em En
| MEDLINE
| ID: mdl-38767698
ABSTRACT
PURPOSE:
To study the long-term effect of transsphenoidal surgery (TSS) on headache in patients with non-functioning pituitary adenoma (NFPA) and identify factors predicting headache relief following TSS.METHODS:
We evaluated headache in 101 consecutive patients with NFPA who underwent TSS from September 2015 to December 2021, preoperatively and 12-months post-surgery, by using the Migraine Disability Assessment (MIDAS) questionnaire. Health-related quality of life (QoL) was assessed using the EQ-5D visual analogue scale (EQ-VAS).RESULTS:
Of 101 patients, 27 (27%) experienced disabling preoperative headache. Among these, the median total MIDAS score improved from 60 (interquartile range (IQR) 19-140) to 10 (IQR 0-49) (P = 0.004). Additionally, headache frequency over a 90-day period decreased from 45 (IQR 25-83) to 6 (IQR 3-36) days (P = 0.002), and headache intensity decreased from 5 (IQR 4-7) to 4 (IQR 2-7) (P = 0.016) at 12-months post-surgery. At 12 months post-surgery, 18 (67%) of 27 patients with preoperatively disabling headache showed clinically relevant improvement of their headache, 4 (15%) showed deterioration, and 5 (19%) remained unchanged. In patients with clinically relevant improvement of their headache, the EQ-VAS score improved from 50 (IQR 30 - 7) to 80 (IQR 65-86) (P < 0.001). Of the 74 patients with no preoperative headache, 11 (15%) developed postoperative headache. We identified no clinical factors predicting postoperative headache relief.CONCLUSION:
The study supports that clinically significant and long-lasting improvements of disabling headache and QoL can be achieved with TSS in a substantial number of patients with NFPA.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2024
Tipo de documento:
Article